• English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • français 
    • English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • Ouvrir une session
Voir le document 
  •   Accueil de DSpace
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Voir le document
  •   Accueil de DSpace
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Voir le document
JavaScript is disabled for your browser. Some features of this site may not work without it.
Tout DSpace
  • Communautés & Collections
  • Par date de publication
  • Auteurs
  • Titres
  • Sujets

The endocrine effects of multiple folliculogenesis

Thumbnail
Auteur
Messinis, I. E.
Date
2011
DOI
10.1016/j.mefs.2010.08.009
Sujet
Estradiol
FSH
GnRH analogs
GnSAF
IVF
LH
cetrorelix
follitropin
gonadorelin
gonadorelin agonist
gonadorelin antagonist
gonadotropin
gonadotropin surge attenuating factor
inhibin
luteinizing hormone
endocrine function
feedback system
female
fertilization in vitro
follicular phase
follitropin release
hormone inhibition
human
hypophysis
luteal phase
luteinizing hormone release
menstrual cycle
ovary follicle development
ovary function
pregnancy rate
review
Afficher la notice complète
Résumé
Induction of multiple follicular development is a common practice in IVF programmes. Nevertheless, such an approach is not without implications. Apart from the high multiple pregnancy rate, marked changes in the secretion of pituitary and ovarian hormones take place. Estradiol and inhibin are produced in high amounts during the follicular phase and as a result the negative feedback mechanism is potentiated leading to the marked suppression of gonadotropin secretion from the pituitary. The secretion of LH is also reduced in down-regulated cycles as well as in women receiving a GnRH antagonist, while LH levels are maintained stable when a GnRH agonist is used in a short protocol. The suppression of LH secretion is also evident at midcycle with the endogenous LH surge being blocked or markedly attenuated due to the production of gonadotropin surge attenuating factor (GnSAF). Under these conditions, the LH surge is usually premature in relation to the size of the leading follicle resulting in premature luteinization, but can be prevented by the use of GnRH analogs. In IVF cycles, the luteal phase is disrupted due to the suppression of LH levels. Mild protocols might provide a better approach to the ovarian stimulation than conventional protocols resulting in a reasonable success rate of IVF treatment. © 2011 Middle East Fertility Society.
URI
http://hdl.handle.net/11615/30926
Collections
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ. [19735]
htmlmap 

 

Parcourir

Tout DSpaceCommunautés & CollectionsPar date de publicationAuteursTitresSujetsCette collectionPar date de publicationAuteursTitresSujets

Mon compte

Ouvrir une sessionS'inscrire
Help Contact
DepositionAboutHelpContactez-nous
Choose LanguageTout DSpace
EnglishΕλληνικά
htmlmap